Evaluating a program to prevent the commercial sexual exploitation of children in Minnesota
Official title: CE22-003 - A Randomized Controlled Trial Evaluation of the Not a Number Program to Prevent the Commercial Sexual Exploitation of Children (CSEC) and Youth in Minnesota
Funded at University of New Hampshire · NIH-11120823 · Data updated 2026-11-12
This study is testing a program called Not a Number that helps protect kids and teens in Minnesota from being exploited, and it's designed for youth-serving organizations to learn how to better support at-risk youth.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Hampshire NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2026 |
| Funding year | 2024 |
| Award (this year) | $398,585 |
| NIH project number | 5U01CE003406-03 |
| Project ID | NIH-11120823 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are youth in Minnesota who are at risk of commercial sexual exploitation.
✕Less likely to help
Patients who are not at risk of commercial sexual exploitation may not receive any benefit from this research.
What this research studies
This research evaluates the Not a Number (NAN) program, which aims to prevent the commercial sexual exploitation of children and youth in Minnesota. The program is delivered through a train-the-trainer model to at-risk youth and is being assessed for its effectiveness using a rigorous cluster randomized controlled trial methodology. The study will involve collaboration with 24 youth-serving agencies and will utilize a Community Based Participatory Research approach to gather insights from the community on prevention strategies. The research will be conducted over five years, focusing on refining methodologies and implementing the evaluation.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of commercial sexual exploitation among youth in Minnesota.
How similar studies have gone: While the Not a Number program is evidence-supported, this specific evaluation is novel and has not been previously tested.
Where this research is happening
-
University of New Hampshire
Durham, United States Active
Researchers
- Principal investigator: Jones, Lisa M — University of New Hampshire
- Study coordinator: Jones, Lisa M
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.